Navellier & Associates’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-21,848
| Closed | -$1.96M | – | 311 |
|
|
2021
Q1 | $1.96M | Sell |
21,848
-15,304
| -41% | -$1.38M | 0.35% | 93 |
|
|
2020
Q4 | $3.43M | Sell |
37,152
-23,828
| -39% | -$2.2M | 0.62% | 61 |
|
|
2020
Q3 | $6.28M | Sell |
60,980
-1,632
| -3% | -$168K | 1.37% | 19 |
|
|
2020
Q2 | $6.35M | Sell |
62,612
-32
| -0.1% | -$3.24K | 1.51% | 17 |
|
|
2020
Q1 | $4.22M | Sell |
62,644
-8,472
| -12% | -$570K | 0.99% | 18 |
|
|
2019
Q4 | $3.89M | Sell |
71,116
-3,008
| -4% | -$164K | 0.63% | 46 |
|
|
2019
Q3 | $2.77M | Sell |
74,124
-1,456
| -2% | -$54.3K | 0.46% | 58 |
|
|
2019
Q2 | $2.83M | Sell |
75,580
-1,388
| -2% | -$52K | 0.44% | 58 |
|
|
2019
Q1 | $2.29M | Sell |
76,968
-860
| -1% | -$25.6K | 0.36% | 79 |
|
|
2018
Q4 | $2.33M | Buy |
+77,828
| New | +$2.33M | 0.4% | 58 |
|